Surveillance of patients with inflammatory bowel disease

详细信息    查看全文

• 作者：Jessica X. Yu ; MD^a (Gastroenterology Fellow) ; James E. East ; MD(Res) ; FRCP^b (Consultant Gastroenterologist ; Endoscopist ; Honorary Senior Clinical Lecturer ; Clinical Lead for Endoscopy ; Clinical Director of Bowel Cancer Screening Oxfordshire) ; Tonya Kaltenbach ; MD MAS^c ; ^{endoresection@me.com} (Associate Professor Clinical Medicine)
• 关键词：Inflammatory bowel disease ; Chromoendoscopy ; Image-enhanced endoscopy ; Colorectal cancer ; Dysplasia ; Colonoscopy ; Surveillance ; SCENIC
• 刊名：Best Practice & Research Clinical Gastroenterology
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：30
• 期：6
• 页码：949-958
• 全文大小：920 K
• 卷排序：30

文摘

Patients with inflammatory bowel disease involving the colon are at increased risk for developing colorectal cancer. Colonoscopy surveillance is important to identify and treat IBD associated dysplasia. The SCENIC consensus provides evidence-based recommendations for optimal surveillance and management of dysplasia in IBD. Chromoendoscopy, with the surface application of dyes to enhance mucosal visualization, is the superior endoscopic surveillance strategy to detect dysplasia. Most dysplasia is visible, and can be endoscopically resected. Future studies should determine the effect of new surveillance strategies on the incidence of CRC and mortality in patients with IBD.